Platform Study of Novel Ruxolitinib Combinations in Myelofibrosis Patients
Clinical trial NCT04097821 · TERMINATED
Trial details
- NCT number
- NCT04097821
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-26
- Primary completion
- 2023-05-03
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.